Valeo Pharma Inc VPHIF

Healthcare

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.

GREY:VPHIF - Post by User

Valeo Pharma Inc > Hesperco get the green light with Health Canada

<< Previous

Bullboard Posts

Next >>

Comment by bmo1212on Sep 08, 2020 3:49pm

128 Views

Post# 31521573

RE:Hesperco get the green light with Health Canada

You do realize that this product is just another a Hesperidin based product which is a flavanone glycoside found in citrus fruits?
Its aglycone form is called hesperetin. Its name is derived from the word "hesperidium", for fruit produced by citrus trees. Hesperidin was first isolated in 1828 by French chemist Lebreton from the white inner layer of citrus peels

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale